Task: Answer the multiple choice question.
Query: Which drug exhibits a 16.578% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a O=C(Cn1nnc(-c2ccccc2-n2cnnn2)n1)NCc1ccccc1
b Cc1cc(=O)oc2cc(OCC(=O)N3CCN(c4ccccc4)CC3)c(Cl)cc12
Answer: b. Cc1cc(=O)oc2cc(OCC(=O)N3CCN(c4ccccc4)CC3)c(Cl)cc12
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1cc(=O)oc2cc(OCC(=O)N3CCN(c4ccccc4)CC3)c(Cl)cc12
Cc1cc(=O)oc2cc(OCC(=O)N3CCN(c4ccccc4)CC3)c(Cl)cc12
6-chloro-4-methyl-7-[2-oxo-2-(4-phenyl-1,4-diazinan-1-yl)ethoxy]chromen-2-one